InvestorsHub on MSN
20/20 BioLabs licenses kidney disease prediction technology from ROKIT Healthcare
BioLabs, Inc. (NASDAQ:AIDX) announced it has signed an exclusive U.S. technology licensing and access agreement with ROKIT ...
Shares of 20/20 Biolabs, Inc. AIDX are trading lower Tuesday after the company announced that it entered into an exclusive U.S. technology license and access agreement with ROKIT Healthcare. 20/20 ...
This is Part 6 of Embedded Bias, a series revealing how race-based clinical algorithms pervade medicine and why it's so difficult to change them. NEW YORK — One Brooklyn Health, a safety net hospital ...
Roche Holdings AG received CE-mark for the Kidney Klinrisk algorithm, an AI-based tool developed in collaboration with Klinrisk Inc. to stratify risk and assess the progressive decline in kidney ...
Expands OneTest for Longevity with Chronic Kidney Disease Risk Assessment GAITHERSBURG, Md., March 24, 2026 (GLOBE NEWSWIRE) ...
Removing race from the eGFR was a long process that divided the field of nephrology for years. After a task force for the ...
For years, it was harder for Black patients to secure a coveted spot on the national kidney transplant waitlist because a clinical algorithm was making Black patients appear healthier than they were.
A machine-learning algorithm can use demographic, symptomatic, and clinical data to accurately predict the health-related quality of life (QoL) of patients with kidney stones, new research shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results